Concepedia

Jonathan Fialkov

JF

Statistics

Publications

5

Citations

184

H-Index

5

Active since

1998

Affiliations

University of Iowa(Current)

Health Sciences Centre

Université de Sherbrooke

Sunnybrook Health Science Centre

Astellas Pharma (United States)

Jonathan Fialkov is an author at University of Iowa specializing in renal pathology, urology, and medicine.

Top concepts

Publications per year

1998–2018

5

Publications

5

Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.

Thomas S. Griffith, Jonathan Fialkov, David L. Scott et al. · PubMed · 2002 · 80 citations

, , +20

A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study)

David Staskin, Sender Herschorn, Jonathan Fialkov et al. · International Urogynecology Journal · 2017 · 35 citations · Full text

REASSESSING THE EFFICACY OF THE DORNIER MFL-5000 LITHOTRIPTOR

Jonathan Fialkov, Sean P. Hedican, Bernard Fallon · The Journal of Urology · 2000 · 33 citations

Fournier’s gangrene with an unusual urologic etiology

Jonathan Fialkov, Kevin T. Watkins, Bernard Fallon et al. · Urology · 1998 · 18 citations

, , +10

Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER)

Sender Herschorn, David Staskin, Le Mai Tu et al. · Health and Quality of Life Outcomes · 2018 · 18 citations · Full text

1–5 of 5